Healthcare Global Enterprises
Healthcare Global Enterprises (HCG), headquartered in India, is a leading player in the oncology and healthcare sector. Established in 2001, HCG has made significant strides in providing comprehensive cancer care, with a network of hospitals and clinics across major operational regions in India and beyond. HCG is renowned for its advanced cancer treatment services, including radiation therapy, chemotherapy, and surgical oncology, distinguished by its commitment to personalised patient care and cutting-edge technology. The company has achieved notable milestones, such as being the first to introduce a dedicated cancer hospital in India, solidifying its position as a pioneer in the industry. With a focus on innovation and excellence, HCG continues to enhance its market position, recognised for its high standards of care and successful patient outcomes.
DitchCarbon Score
How does Healthcare Global Enterprises's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Healthcare Global Enterprises's score of 41 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Healthcare Global Enterprises's reported carbon emissions
In 2023, Healthcare Global Enterprises reported total carbon emissions of approximately 6,800,000,000 kg CO2e, with emissions distributed across various scopes: 2,929,130 kg CO2e for Scope 1, 21,769,000 kg CO2e for Scope 2, and 6,800,000,000 kg CO2e for Scope 3. This indicates a significant reliance on indirect emissions, particularly in Scope 3, which encompasses the majority of their carbon footprint. In 2022, the company’s emissions were notably higher, with Scope 1 emissions at 118,000,000 kg CO2e and Scope 2 emissions at 171,000,000 kg CO2e. This suggests a substantial reduction in Scope 1 and Scope 2 emissions in 2023, reflecting a commitment to improving operational efficiency and reducing direct emissions. Despite these reductions, there are currently no publicly disclosed reduction targets or climate pledges from Healthcare Global Enterprises, indicating a potential area for growth in their sustainability strategy. The absence of specific reduction initiatives may limit their ability to address the broader climate impact effectively. Overall, while the company has made strides in reducing its direct emissions, the overwhelming majority of its carbon footprint remains in Scope 3, highlighting the need for comprehensive strategies to tackle indirect emissions in the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 118,000,000 | 0,000,000 | 000,000 |
| Scope 2 | 171,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 6,800,000,000 | 0,000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Healthcare Global Enterprises is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
